Q321 · What is Quality Risk Management (QRM)? How…

Q321 · Category G: Quality management and compliance systems (Q301–Q350)

Quality Risk Management (QRM) is a systematic process for assessing, controlling, communicating and reviewing risks to medicine quality. It goes beyond simply complying with rules: it proactively and prospectively identifies “where things could go wrong” and allocates resources and attention according to the severity, likelihood and detectability of the risks. In pharmaceutical wholesale, QRM can be applied at every stage: assessing compliance risks when selecting suppliers; assessing cross-contamination risks when designing warehouse layouts; assessing the risk of temperature excursions when preparing cold-chain transport plans; and assessing the ultimate impact on product quality when handling deviations. Through QRM, businesses can move from “reactive response” to “proactive management”, concentrating limited resources on the highest-risk areas.

📘 Regulatory basis

The International Council for Harmonisation (ICH) Q9 guideline, Quality Risk Management, is a globally recognised authoritative standard. Although GDP does not mandate a complete QRM system in the same way as GMP, modern regulatory thinking has incorporated risk-based principles in depth. For example, the frequency and scope of internal audits should be determined on the basis of risk assessment.

📗 Drew Tang's recommendations

We recommend that clients do not view QRM as extra paperwork. Start with simple risk assessment tools, such as Failure Mode and Effects Analysis (FMEA) or a risk matrix. Whenever you carry out change control, handle a major deviation or prepare an annual audit plan, ask: “What is the biggest risk here?” Documenting the risk assessment process and its results can show regulators that your decisions are justified.

📕 Risk notice

A lack of risk-management thinking may lead a business to spread its efforts evenly across all issues, overlooking its most critical weaknesses. In a regulator’s view, a company that cannot identify and prioritise its key risks has a blind quality system. If an investigation after an incident finds that the relevant risk could have been foreseen but was not addressed, the company’s liability will be substantially increased.

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

What is Quality Risk Management (QRM)? How is it applied in pharmaceutical wholesale?

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang